Coriolis Pharma is First CRO in the World to Routinely Use Archimedes from Malvern Instruments
Malvern Instruments Ltd
Enigma Business Park
Malvern Worcestershire, WR14 1XZ
Press release date: September 5, 2013
Team also publishes paper examining ability to distinguish between protein aggregates and oil droplets in biopharmaceutical formulations
Malvern, UK: Coriolis Pharma (Martinsried, Germany) has become the first pharmaceutical contract research organization in the world to routinely use Archimedes, a new analytical instrument supplied by Malvern Instruments. Coriolis Pharma specializes in formulation development for biopharmaceuticals such as proteins, peptides and vaccines and offers a wide variety of services to support product development.
Archimedes is a new system that uses the technique of resonant mass measurement (RMM) to detect and accurately count particles from 50 nm to 5 µm in diameter, and to measure their buoyant mass, dry mass and size. It has applications in the quantitative characterization of protein aggregates in the size range currently of new regulatory interest, from 0.2 µm to 2 µm diameter, where aggregates are considered to have a high likelihood of eliciting an unwanted immune response. Uniquely for this size range, Archimedes distinguishes between proteinaceous material and contaminants such as silicone oil.
“The teams at Coriolis Pharma have extensive expertise in protein analysis, especially in the field of protein aggregation and degradation, and were early to recognize the benefits of applying resonant mass measurement within our formulation development regimes,“ said Dr. Andrea Hawe, CSO from Coriolis Pharma. “Our pioneering testing and adoption of the highly innovative Archimedes now enables us to more easily measure protein aggregates and silicone oil droplets in a critically important size range. This has added a new dimension to our protein characterization capabilities and to the service we provide for our clients."
In the July 2013 issue of the Journal of Pharmaceutical Sciences, scientists at Coriolis Pharma, together with colleagues at Leiden University in The Netherlands and Ludwig Maxmilians University in Germany, published a paper reporting work using RMM and micro-flow imaging to examine the quantitative differentiation of protein particles and silicone oils over a large size range.
Distinguishing between these two entities is pertinent to the development of biopharmaceuticals, in particular for products in prefilled syringes or cartridges where silicone oil may be used as a lubricant in the delivery device. The high accuracy of discrimination using Archimedes for different types of protein particles, and different ratios of protein particle to silicone oil droplets, and also the robustness of the technique were all attributed to the straightforward categorization of particles and droplets according to buoyant mass.
“Archimedes is now part of our routine offering for clients seeking support in formulation development. In addition we can run samples as part of feasibility studies for future work or as standalone projects,” continued Dr. Andrea Hawe. “Having this technique available means we are able to offer more extensive protein characterization services to our clients that help them in the drive to more rapidly develop and commercialize new therapeutic solutions."
For details of the services provided by Coriolis Pharma please visit http://www.coriolis-pharma.com/?utm_source=PRutm_medium=webutm_campaign=RMM
To find out more about Archimedes go to http://www.malvern.com/archimedes
About Coriolis Pharma
Coriolis Pharma is a world leading independent service provider for formulation research and development of biopharmaceutical drugs (proteins, peptides, monoclonal antibodies, RNA/DNA etc.) and vaccines.
This is complemented by outstanding capabilities and know-how in the fields of subvisible particle analysis and aggregation characterization, including the latest innovative technologies (e.g. Archimedes) as well as GMP compliant analytics.
Coriolis Pharma is specialized in provision of:
• Formulation development service
• Lyophilization development service
• Stability testing and forced degradation studies
• (GMP) Contract Analytical Services
• Orthogonal analysis of sub-visible aggregates and particles
• Scientific expertise
Located in Martinsried, Munich (Germany), Coriolis Pharma’s vision is to remain the trendsetter in integrating cutting-edge technologies into innovative (bio)pharmaceutical formulation development applying the highest professional standards.
About Malvern Instruments
Malvern provides the materials and biophysical characterization technology and expertise that enables scientists and engineers to understand and control the properties of dispersed systems. These systems range from proteins and polymers in solution, particle and nanoparticle suspensions and emulsions, through to sprays and aerosols, industrial bulk powders and high concentration slurries. Used at all stages of research, development and manufacturing, Malvern’s materials characterization instruments provide critical information that helps accelerate research and product development, enhance and maintain product quality and optimize process efficiency.
Our products reflect Malvern’s drive to exploit the latest technological innovations and our commitment to maximizing the potential of established techniques. They are used by both industry and academia, in sectors ranging from pharmaceuticals and biopharmaceuticals to bulk chemicals, cement, plastics and polymers, energy and the environment.
Malvern systems are used to measure particle size, particle shape, zeta potential, protein charge, molecular weight, mass, size and conformation, rheological properties and for chemical identification, advancing the understanding of dispersed systems across many different industries and applications.
Headquartered in Malvern, UK, Malvern Instruments has subsidiary organizations in all major European markets, North America, China, Japan and Korea, a joint venture in India, a global distributor network and applications laboratories around the world. www.malvern.com
For press information, please contact:
Trish Appleton, Kapler Communications
Phoenix House, Phoenix Park, Eaton Socon, Cambridgeshire, PE19 8EP, UK
Tel: +44 (0)1480 471059
Fax: +44 (0)1480 471069
Marisa Fraser, Malvern Instruments Inc.
117 Flanders Road, Westborough, MA 01581-1042 USA
Tel: +1 508 768 6400
Fax: +1 508 768 6403
Please send sales enquiries to:
Alison Vines, Malvern Instruments Ltd
Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ UK
Tel: +44 (0) 1684 892456; Fax: +44 (0) 1684 892789